The short version
Eden is a flat-rate telehealth provider. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $3,868 (month-to-month plan, reported), which places it 23 of 30 ranked telehealth providers. Verification status: reported.
The numbers, plan by plan
- Semaglutide (standard, month-to-month plan): no rankable price. Eden's public pricing is internally inconsistent: a January 2026 article says $149 the first month then $249 per month, while current product callouts advertise $99 per month medication plus a membership of $39 the first month and $99 thereafter. Unranked until checkout terms resolve it.
- Tirzepatide (standard, injection, month-to-month plan): $329 per month after an introductory $249 per month for the first 1 month. Status: reported, checked June 16, 2026. Reported by a June 16, 2026 comparison: about $249 for the first month, then $329 to $349 per month; a current authoritative checkout did not substantiate it.
Fees and what the price includes
A membership or program fee of $99 per month is billed on top of the medication ($39 for the first month), so the advertised medication price is not the monthly total. Shipping is included. The clinician consultation is included. The price does not change with dose.
How this pricing structure plays out over a year
The first 1 month costs $249 all-in; from month 2 the recurring cost is $329 a month, so the advertised $249 covers 6% of the first year's spend and the recurring price covers the rest. The price does not move with dose, which removes the largest hidden cost in this market; a patient at 15 mg pays what a patient at 2.5 mg pays.
Compared with the field
On tirzepatide, Eden's lowest twelve-month total of $3,868 is $2,368 above the lowest (Trimi, $1,500) and above the median of $3,090 across 30 ranked providers, placing it 23 of 30. On the value score it scores 61 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care, verification.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: 503A (Eden-owned Contigo Compounding, acquired August 19, 2025, plus named network partners). Named pharmacies: Contigo Compounding (Eden-owned). Commitment: month-to-month. Cancellation: Cancel anytime.
Questions to ask Eden before paying
Ask, in writing: What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Broad menu including brand, compounded and oral options. All-in pricing without a membership.
What to weigh against it
Pricing pending verification. Marketing-heavy site makes the recurring price hard to locate.
Who should choose Eden
Patients who want one provider with many medication forms. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Eden's about page says it serves all 50 states and DC, and its August 19, 2025 announcement says it acquired Contigo Compounding, a licensed 503A pharmacy (ownership of a pharmacy does not mean every prescription is filled there; Eden also names other partners). Its semaglutide pricing is internally inconsistent ($149/$249 versus $99 plus a $39/$99 membership) and its tirzepatide price rests on a third-party report. Verified against the provider's own pages on 2026-08-25 (first-party verification pass).